Avoid contact with eyes and mucous membranes. To prevent repigmentation, during treatment and maintenance therapy, sun exposure on treated skin should be avoided by application of a broad spectrum sunscreen (SPF 15 or greater) or by use of protective clothing. If this condition occurs, discontinue treatment and consult your physician. No representation is made as to generic status or bioequivalency. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.To gradually lighten hyperpigmentation of the skin such as age spots, liver spots, freckles or hyperpigmentation that can occur as a result of pregnancy or the use of oral contraceptives.For external use only. If no improvement is seen after 2 months of treatment, use of this product should be discontinued.

However, treatment should be limited to relatively small areas of the body at one time, since some patients experience a transient skin reddening and a mild burning sensation which does not preclude treatment.Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F) [see USP Controlled Room Temperature]All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. No representation is made as to generic status or bioequivalency. There is no recommended dosage for pediatric patients under 12 years of age except under the … The physician should be familiar with the contents of this insert before prescribing or dispensing this medication.Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight sustains melanocytic activity. Treatment with hydroquinone has resulted in positive findings for genetic toxicity in the Ames assay in bacterial strains sensitive to oxidizing mutagens, in in vitro studies in mammalian cells, and in the Animal reproduction studies have not been conducted with topical hydroquinone. If this occurs, the medication should be discontinued and the physician notified immediately.There have been no systemic reactions reported from the use of topical hydroquinone.

Keep out of reach of children.

There is no recommended dosage for pediatric patients under 12 years of age except under the … Because many drugs are excreted in human milk, caution should be exercised when topical hydroquinone is administered to a nursing woman.Safety and effectiveness for pediatric patients below the age of 12 years have not been established.The following adverse reactions have been reported: dryness and fissuring of paranasal and infraorbital areas, erythema, and stinging. Minor redness is not a contraindication, but where there is itching or vesicle formation or excessive inflammatory response further treatment is not advised. The safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. Topical application of hydroquinone produces a reversible depigmentation of the skin by inhibition of the enzymatic oxidation of tyrosine to 3, 4-dihydroxyphenylalanine (dopa) (Denton, C. et al., 1952)Prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. 89 ($19.35/Ounce) Get it as soon as Mon, Sep 14. Please NOTE: This is not an Orange Book product and has not been subjected to FDA therapeutic or other equivalency testing. Store at room temperature (15-30°C / 59-86°F).Butylated Hydroxy Toluene, Butylparaben, Cetearyl Alcohol, Cetyl Alcohol, Disodium EDTA, Ethoxydiglycol, Fragrance/Parfum (Carubba C6929), Glycerin, Lactic Acid, L-Ascorbic Acid USP, Methylparaben, Phenyl Trimethicone, PPG-2 Myristyl Ether Propionate, Propylparaben, Sodium Cetearyl Sulfate, Sodium Lauryl Sulfate, Sodium Metabisulfite, Tocopheryl Acetate, Water/Eau.Gavreto (pralsetinib) is an oral selective RET kinase inhibitor for the...Onureg (azacitidine) is a nucleoside metabolic inhibitor indicated for the...Qdolo (tramadol hydrochloride) is an opioid agonist indicated in adults for ...Xaracoll (bupivacaine hydrochloride) is a fully bioresorbable collagen implant...The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records.